Subsequently, it was confirmed in mouse hepatocellular carcinoma model that IL-37 has the effect of inhibiting tumor growth, possibly by increasing the recruitment of CD57+ NK cells to kill cancer cells [21]. This evidence concerns the gene IL37 and neoplasm.